PDT Partners, LLC - ARBUTUS BIOPHARMA CORP ownership

ARBUTUS BIOPHARMA CORP's ticker is ABUS and the CUSIP is 03879J100. A total of 73 filers reported holding ARBUTUS BIOPHARMA CORP in Q4 2018. The put-call ratio across all filers is 0.81 and the average weighting 0.1%.

Quarter-by-quarter ownership
PDT Partners, LLC ownership history of ARBUTUS BIOPHARMA CORP
ValueSharesWeighting
Q1 2021$241,000
+123.1%
72,500
+140.1%
0.02%
+183.3%
Q1 2019$108,000
-6.9%
30,2000.0%0.01%0.0%
Q4 2018$116,000
-48.9%
30,200
+25.6%
0.01%
-33.3%
Q3 2018$227,000
-53.6%
24,050
-64.1%
0.01%
-52.6%
Q2 2018$489,000
+34.7%
66,965
-7.6%
0.02%
+58.3%
Q1 2018$363,000
-13.4%
72,500
-12.7%
0.01%0.0%
Q4 2017$419,000
+437.2%
83,000
+264.0%
0.01%
+140.0%
Q3 2016$78,000
-25.7%
22,800
-24.5%
0.01%
-37.5%
Q2 2016$105,00030,2000.01%
Other shareholders
ARBUTUS BIOPHARMA CORP shareholders Q4 2018
NameSharesValueWeighting ↓
Whitefort Capital Management, LP 11,895,477$24,147,81812.66%
Two Seas Capital LP 8,280,818$16,810,0613.38%
FourWorld Capital Management LLC 1,341,907$2,724,0710.51%
Tejara Capital Ltd 180,077$365,5560.21%
Woodline Partners LP 4,719,903$9,581,4030.11%
Hudson Bay Capital Management LP 8,299,808$16,848,6100.07%
Kepos Capital LP 155,691$3160.06%
Virtus ETF Advisers LLC 40,040$81,2810.05%
Centiva Capital, LP 1,071,705$2,175,5610.05%
Kades & Cheifetz LLC 20,000$40,6000.03%
View complete list of ARBUTUS BIOPHARMA CORP shareholders